Loeb
& Loeb LLP
345
Park Avenue
New
York, NY 10154-1895
|
Direct
212.407.4000
Main
212.407.4000
Fax
212.407.4990
|
Re:
|
China
Cord Blood Corporation
Form
20-F for the Year Ended March 31, 2010
Filed
July 16, 2010
File No.
001-34541
|
Tia
Jenkins
October
4, 2010
Page
2
|
1.
|
We
remind you to provide us the acknowledgements listed in the closing
comments of our letter.
|
|
COMPANY RESPONSE: The acknowledgements referenced in the Staff’s comment are included at the end of this letter. |
|
2.
|
We
note your response to comment nine of our letter dated August 19,
2010. Please expand your discussion of critical accounting
estimates related to valuation of inventories to quantify your estimates
of growth in the number of matches and explain the basis for your
estimates. Furthermore, please describe the range of years you
estimate it will take for you to recover the costs capitalized in
inventory.
|
COMPANY RESPONSE: | ||
We propose to revise the disclosure under the heading “Valuation of inventories” on page 73 as follows: | ||
“[. . .] The number of cord blood units that can be matched for a fee involves estimates of the future demand for cord blood units for transplants, the probability of finding a match in light of number of donated cord blood units stored and our industry knowledge. As of March 31, 2010, the weighted average remaining useful life of the donated cord blood units was estimated to be at least 19 years. Based on the historical increase in the number of cord blood matching inquiries and the number of successful matches of donated units, the Company estimates the number of successful matches of donated units will increase by 7% to 10% per annum. Based on the estimation, the carrying amount of the donated units will be recovered in approximately 13 years. If medical research discovers new and more effective medical procedures that make cord blood transplants more effective, or if medical research discovers more diseases that cord blood transplants can be used to treat, the estimated number of cord blood units that can be matched may increase. Conversely, if there are no new developments in medical science to overcome some of the current technical and therapeutic limitations on the use of cord blood in medical treatment, the estimated number of cord blood units that can be matched may decrease. Any of the estimation variables which differ from our expectations may result in material adjustments to direct costs in future periods.” |
Tia
Jenkins
October
4, 2010
Page
3
|
|
3.
|
We
note from your response to comment nine of our letter dated August 19,
2010 that you believe no provision is necessary to reduce inventory to its
net realizable value and that you expect it will be recovered in 13
years. Please tell us how you took into account the time value
of money and the discounting of future cash flows in determining that no
provision was necessary.
|
COMPANY RESPONSE: | ||
The Company believes that undiscounted cash flow should be used to estimate the net realizable value in considering the recoverability of the carrying value of inventories. With reference to Concepts Statement 5, paragraph 67(d), the term net realizable value is defined as the non-discounted amount of cash or cash equivalents into which an asset is expected to be converted in due course of business less direct costs, if any, necessary to make that conversion. The recoverability of the donated units is estimated by the forecast matching fees to be generated in the future without applying present value discounting. We propose to add the following disclosure on page 73: “The estimates are calculated based on forecast fees to be generated from estimated successful matches in the future without discounting the fees to their present values.” |
|
4.
|
Please
tell us whether you cease recognizing storage revenue related to
subscribers who are delinquent beyond a certain period that would indicate
that collection was no longer reasonably assured. If so, tell
us the delinquency period that serves as the point at which you determine
revenue is no longer reasonably assured. If not, explain to us
why you believe collection continues to be reasonably assured in light of
the delinquency. In your response, tell us the number of
subscribers as of March 31, 2010 who are delinquent in payments for
periods over six months, one year and two years along with the related
amounts.
|
Tia
Jenkins
October
4, 2010
Page
4
|
Over
6 months to 1 year
|
1-2
years
|
Over
2 years
|
||||||||||
Number
of subscribers
|
12,285 | 9,191 | 2,451 | |||||||||
Outstanding
balance (RMB 000's)
|
5,315 | 5,077 | 2,205 | |||||||||
Less:
allowance for doubtful accounts
|
- | (1,575 | ) | (1,386 | ) | |||||||
Net
balance (RMB 000's)
|
5,315 | 3,502 | 819 |
|
5.
|
We
note from your response to comment 7 of our letter dated August 19, 2010
that current processing fees accounts receivable represent amounts due and
subject to payment within one year. Please explain to us the
payment terms related to your invoicing of fees. In other
words, clarify whether amounts billed are due upon receipt of the invoice
or within one year.
|
|
6.
|
We
note from your response to comment 7 of our letter dated August 19, 2010
that 14.3% of your processing fees receivable related to Option Three is
aged for over 1 year. Please explain to us why you believe
collection is reasonably assured when over 14% of your current accounts
receivable for processing fees remain unpaid for over one
year.
|
Tia
Jenkins
October
4, 2010
Page
5
|
|
7.
|
We
note from your response to comment 7 of our letter dated August 19, 2010
that the allowance for doubtful accounts related to current processing
fees receivable is RMB3.3 million. Please clarify for us
whether this allowance represents the allowance on the entire balance of
current processing fees receivable or the balance that is aged over one
year.
|
|
8.
|
Please
provide us with an analysis showing how you computed earnings per share
for the year ended March 31, 2010.
|
Tia
Jenkins
October
4, 2010
Page
6
|
Basic earnings per ordinary share | Basic earnings per redeemable ordinary share | ||||
Numerator
|
● |
Net
income/(loss) of CCBS for the three months ended June 30, 2009
attributable to CCBS ordinary
shareholders, adjusted for the accretion to the redeemable ordinary shares
redemption
value; plus,
|
● |
Net
income/(loss) of CCBS for the three months ended June 30, 2009
attributable to CCBS redeemable ordinary shareholders
|
|
●
|
Net income of the Company for the nine months ended March 31, 2010 attributable to the Company’s ordinary shareholders, adjusted for the accretion to redemption value of the redeemable noncontrolling interests (i.e. redeemable CCBS ordinary shares that were outstanding from July 1, 2009 through August 2009) | ||||
Denominator
|
● |
The
weighted-average number of ordinary shares of CCBS outstanding during the
three-month period ended June 30, 2009, as adjusted by the exchange ratio
effected in the Share Exchange; plus,
|
● |
The
weighted-average number of redeemable ordinary shares of CCBS outstanding
during the three-month period ended June 30, 2009, as adjusted by the
exchange ratio effected in the Share Exchange.
|
|
●
|
The weighted-average number of ordinary shares of the Company for the nine-month period ended March 31, 2010. |
Tia
Jenkins
October
4, 2010
Page
7
|
|
·
|
the
Company is responsible for the adequacy and accuracy of the disclosure in
the filing;
|
|
·
|
Staff
comments of changes to disclosure in response to Staff comments do not
foreclose the Commission from taking any action with respect to the
filing; and
|
|
·
|
the
Company may not assert Staff comments as a defense in any proceeding
initiated by the Commission or any person under the federal securities
laws of the United States.
|
Sincerely, | |||
/s/ Mitchell Nussbaum | |||
Mitchell
Nussbaum
Partner
Loeb
& Loeb LLP
|
cc:
|
Albert
Chen, China Cord Blood Corporation
Virginia
Tam, Jones Day
Harry
Yu, KPMG
|
Tia
Jenkins
October
4, 2010
Page
8
|
The
Company has two class of ordinary shares for the year ended March 31,
2010, being ordinary shares and redeemable ordinary shares. The
Company calculated the earnings per share applying two class
method. On June 30, 2009, the Participating Shareholders who
held redeemable ordinary shares of China Cord Blood Services Corporation
("CCBS") exchanged the redeemable shares for the ordinary shares of the
Company and therefore, in calculating the earnings per
share.
|
|||
1.Basic
earnings per redeemable ordinary share can be analyzed as
follows:
|
Net
loss attributable to parent company from April 1, 2009 to June
30, 2009
|
A
|
(4,592)
|
|
Accretion
to redeemable ordinary shares redemption value
|
B
|
(5,870)
|
|
Net
loss attributable to ordinary shareholders
|
C =
A + B
|
(10,462)
|
|
Denominator
(weighted average number of shares outstanding from April 1, 2009 to
June 30, 2009)
|
|||
-
Ordinary shares
|
D
|
43,237,100
|
|
-
Redeemable ordinary shares
|
E
|
14,614,140
|
|
F =
D + E
|
57,851,240
|
||
Allocation
of undistributed loss
|
|||
-
Ordinary shares
|
G =
C x D / F
|
(7,819)
|
|
-
Redeemable ordinary shares
|
H =
C x E / F
|
(2,643)
|
|
(10,462)
|
|||
Allocation
of net (loss)/income (numerator):
|
|||
-
Ordinary shares
|
I =
G
|
(7,819)
|
|
-
Redeemable ordinary shares
|
J =
K – I
|
3,227
|
|
K =
A
|
(4,592)
|
||
Basic
earnings per redeemable ordinary shares
|
= J
/ E
|
0.22
|
Tia
Jenkins
October
4, 2010
Page
9
|
2.Basic
earnings per ordinary share for the year ended March 31, 2010 can be
analyzed as follows:
|
||||
Weighted
average number of redeemable ordinary shares for the year =
14,614,190 * 91/365
=3,643,525
|
||||
Adjusted
net income attributable to the parent company for the year ended
March 31, 2010:
|
Net
income attributable to parent company for the year ended
March 31, 2010
|
49,177
|
|
Accretion
to redemption value of redeemable noncontrolling interests
|
(99)
|
|
Adjusted
net income attributable to the parent company
|
49,078
|
|
Net
income allocated to ordinary shares = 49,078 - 3,643,525*0.22/1000 =
48,273
|
||
Weighted
average number of ordinary shares for the year ended March 31, 2010 =
58,854,605
|
||
Earnings
per ordinary shares = 48,273/58,854,605*1000 = 0.82
|
||
3.Diluted
earnings per redeemable ordinary share
|
||
As
of June 30, 2009, there were 2,051,981 dilutive potential ordinary shares,
being the share options granted to the directors and executives of
CCBS. As the Company was subject to a loss for the period, the
dilutive potential shares have an anti-dilutive effect on earnings per
redeemable ordinary share
|
||
4.Diluted
earnings per ordinary share
|
||
As
of March 31, 2010, there were 3,180,716 dilutive potential ordinary
shares. The diluted earnings per ordinary share can be analyzed
as follows:
|
||
Net
income allocated to ordinary share
|
48,273
|
|
Weighted
average number of ordinary shares for the year ended
March 31, 2010
|
58,854,605
|
|
Dilutive
potential ordinary shares
|
3,180,716
|
|
62,035,321
|
||
Diluted
earnings per ordinary share
|
0.78
|